Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16372730rdf:typepubmed:Citationlld:pubmed
pubmed-article:16372730lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:16372730lifeskim:mentionsumls-concept:C0025353lld:lifeskim
pubmed-article:16372730lifeskim:mentionsumls-concept:C0020514lld:lifeskim
pubmed-article:16372730pubmed:issue49lld:pubmed
pubmed-article:16372730pubmed:dateCreated2005-12-23lld:pubmed
pubmed-article:16372730pubmed:abstractTextHyperprolactinaemia is associated with drugs used in mental health to treat psychosis (antipsychotics) and affects a significant number of service users. The condition causes endocrine disturbances, including sexual dysfunction, amenorrhoea and infertility. In the longer term, service users are also at risk of disabling conditions such as osteoporosis. Early detection of hyperprolactinaemia enables safer use of antipsychotic drugs. This article focuses on neuroendocrine adverse effects and how this problem can be addressed.lld:pubmed
pubmed-article:16372730pubmed:languageenglld:pubmed
pubmed-article:16372730pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16372730pubmed:citationSubsetNlld:pubmed
pubmed-article:16372730pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16372730pubmed:statusMEDLINElld:pubmed
pubmed-article:16372730pubmed:issn0954-7762lld:pubmed
pubmed-article:16372730pubmed:authorpubmed-author:ShawMichaelMlld:pubmed
pubmed-article:16372730pubmed:issnTypePrintlld:pubmed
pubmed-article:16372730pubmed:volume101lld:pubmed
pubmed-article:16372730pubmed:ownerNLMlld:pubmed
pubmed-article:16372730pubmed:authorsCompleteYlld:pubmed
pubmed-article:16372730pubmed:pagination24-6lld:pubmed
pubmed-article:16372730pubmed:meshHeadingpubmed-meshheading:16372730...lld:pubmed
pubmed-article:16372730pubmed:meshHeadingpubmed-meshheading:16372730...lld:pubmed
pubmed-article:16372730pubmed:meshHeadingpubmed-meshheading:16372730...lld:pubmed
pubmed-article:16372730pubmed:meshHeadingpubmed-meshheading:16372730...lld:pubmed
pubmed-article:16372730pubmed:meshHeadingpubmed-meshheading:16372730...lld:pubmed
pubmed-article:16372730pubmed:meshHeadingpubmed-meshheading:16372730...lld:pubmed
pubmed-article:16372730pubmed:articleTitleDetecting hyperprolactinaemia in mental health patients.lld:pubmed
pubmed-article:16372730pubmed:affiliationCommunity Treatment Team, South West Yorkshire Mental Health NHS Trust.lld:pubmed
pubmed-article:16372730pubmed:publicationTypeJournal Articlelld:pubmed